Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Fallopian Tube Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Penile Neoplasms 2Ovarian Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Ovarian Epithelial 2Anus Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thymoma 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Kaposi 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Pinealoma 1Parathyroid Neoplasms 1

Interventions

Carboplatin 3Bevacizumab 3olaparib 2niraparib 2anlotinib 2Paclitaxel 2Diet, Mediterranean 2Blood Specimen Collection 2temsirolimus 1relacorilant 1pembrolizumab 1nintedanib 1liposomal doxorubicin 1lenvatinib 1entinostat 1avelumab 1Trabectedin 1Tissue Banks 1Papanicolaou Test 1Ocoxin 1NUC-1031 1Gemcitabine 1Food, Formulated 1Filgrastim 1Diffusion 1Dexamethasone 1Cell Count 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Diseases × entinostat × Gynecologic × Clear all
NCT02915523 2024-01-10

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Syndax Pharmaceuticals

Phase 1/2 Completed
140 enrolled 25 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Diseases, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡